Manuel F. Jiménez‐Navarro

Author

Hospital Clínico Universitario Virgen de la Victoria ORCID

Also Known As

Arturo Evangelista Masip, David García-Dorado, Fernando Lozano, Inigo Lozano, Jiménez-Navarro, Manuel, Jiménez-Navarro, Manuel F., Josepa Mauri Ferre, M F Jimenez Navarro, M F Jimenez-Navarro, M F Jiménez-Navarro

451

Publications

10.4K

Citations

H-Index

131

Concepts

All Affiliations

Hospital Clínico Universitario Virgen de la Victoria Universidad de Málaga Instituto de Investigación Biomédica de Málaga Centro de Investigación en Red en Enfermedades Cardiovasculares Instituto de Salud Carlos III

About

Manuel F. Jiménez‐Navarro is an author at Hospital Clínico Universitario Virgen de la Victoria specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	38	1.3K
2	Public Health	11	12	775
3	Health Sciences	5	5	146
4	Engineering	3	3	74
5	Nursing	1	1	32

Manuel F. Jiménez‐Navarro

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries Guy De Backer, Piotr Jankowski, Kornelia Kotseva, Atherosclerosis Cardiovascular EpidemiologyCardiovascular DiseaseCoronary Artery DiseaseHyperlipidemiaDyslipidemia	2019	350
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Mattie Lenzen, Eric Boersma, Wilma J.M. Scholte op Reimer, European Heart Journal	2005	189
Prevalence of Heart Failure in the Spanish General Population Aged Over 45 Years. The PRICE Study Manuel Anguita Sánchez, María G. Crespo Leiro, Eduardo de Teresa Galván, Revista Española de Cardiología (English Edition) Heart FailureCardiovascular EpidemiologyCardiovascular DiseaseHealth PolicyHealth Economics	2008	185
Impact of Diabetes on Mortality in Patients With Myocardial Infarction and Left Ventricular Dysfunction Alvaro M. Murcia, Charles H. Hennekens, Gervasio A. Lamas, Archives of Internal Medicine	2004	152
Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus Lidia Sánchez‐Alcoholado, Daniel Castellano‐Castillo, Laura Jordán-Martínez, Frontiers in Microbiology	2017	122
Factors Predicting and Having an Impact on the Need for a Permanent Pacemaker After CoreValve Prosthesis Implantation Using the New Accutrak Delivery Catheter System Antonio J. Muñoz-García, José M. Hernández-García, Manuel F. Jiménez‐Navarro, JACC: Cardiovascular Interventions Corevalve Prosthesis ImplantationPermanent PacemakerHeart FailureCardiac AnaesthesiaDevice Therapy	2012	73
The importance of genotype-phenotype correlation in the clinical management of Marfan syndrome Víctor Manuel Becerra‐Muñoz, Juan José Gómez‐Doblas, Carlos Porras, Orphanet Journal of Rare Diseases	2018	54
Persistence of secondary mitral regurgitation and response to cardiac resynchronization therapy Fernando Cabrera‐Bueno, M. J. Molina-Mora, Javier Alzueta, European Journal of Echocardiography	2009	53
Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes Macarena Perán, Juan Antonio Marchal, Elena López‐Ruiz, Cytotherapy Cardiac MuscleInduced Pluripotent Stem CellDevelopmental BiologyCardiac ReprogrammingMedicine	2010	50
Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics Jesús Sampedro-Gómez, P. Ignacio Dorado-Díaz, Víctor Vicente-Palacios, Canadian Journal of Cardiology Machine LearningLumen-apposing Metal StentCoronary Artery DiseaseDaily DemographicVascular Surgery	2020	47

Page 1